Correlation of Duration of Antipsychotic Therapy with Hemoglobin Levels in People with Schizophrenia
DOI:
https://doi.org/10.36408/mhjcm.v11i1.908Keywords:
Antipsychotic, Hemoglobin, Hematology, SchizophreniaAbstract
Background: Schizophrenia is a serious mental disorder with various unknown causes accompanied by a collection of positive symptoms, negative symptoms, disorganization in thinking, speaking or movement and cognitive dysfunction. The therapeutic modality used to treat these symptoms is antipsychotic therapy. Over a certain period of time, the use of antipsychotics can cause hematological syndrome which affects the process of red blood cell formation and hemoglobin levels. Low hemoglobin levels can worsen neuronal function in the brain, thereby aggravating symptoms in schizophrenia.
Aim: Analyzing the relationship between duration of antipsychotic therapy <2 years and ≥2 years with hemoglobin levels in schizophrenia patients.
Method: This research is an analytical observational study with a cross-sectional approach in which research subjects were obtained using a consecutive sampling method from medical records of patients with schizophrenia (ODS) at RSJD Dr. Amino Gondohutomo Semarang (n=68) divided into 2 groups consisting of patients with a duration of therapy <2 years and a duration of therapy ≥2 years. The relationship between duration of antipsychotic therapy and hemoglobin levels was analyzed using unpaired t-test.
Result: The mean hemoglobin value for people with schizophrenia in the group with a duration of therapy <2 years is 14.09, while that in the group with a duration of therapy ≥2 years is 14.06 with a p value = 0.928.
Conclusion: There was no relationship between hemoglobin levels in people with schizophrenia and duration of therapy both <2 years and ≥2 years.
Downloads
References
1. Naheed M, Akter KA, Tabassum F, Mawla R, Rahman M. Factors contributing the outcome of Schizophrenia in developing and developed countries: A brief review. International Current Pharmaceutical Journal. 2012;1(4):81-85.
2. Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan RI Tahun 2018. Laporan Nasional Riset Kesehatan Dasar (RISKESDAS) [National Report on Basic Health Research] 2018. Published online 2018:223-225.
3. Gunawan SG. 2007. Psikotropik [Psichotropohic] in Arozal W, Gan S. Edisi 5. Departemen Farmakologi Dan Terapeutik FKUI
4. Fabrazzo M, Prisco V, Sampogna G, et al. Clozapine versus other antipsychotics during the first 18 weeks of treatment: A retrospective study on risk factor increase of blood dyscrasias. Psychiatry Res. 2017;256(8):275-282.
5. Faye AD, Kirpekar VC, Tadke R, Gawande S, Bhave SH. Clozapine-induced bicytopenia: An unusual side effect. Indian J Pharmacol. 2018;50(2):88-90.
6. Szczepocka E, Wysokiński A. Red blood cells parameters in patients with acute schizophrenia, unipolar depression and bipolar disorder. Psychiatr Danub. 2018;30(3):323-330.
7. Ellman LM, Vinogradov S, Kremen WS, et al. Low maternal hemoglobin during pregnancy and diminished neuromotor and neurocognitive performance in offspring with schizophrenia. Schizophr Res. 2012;138(1):81-87.
8. Capeto Coelho I, Aleixo A, Linhares L, Martins A, Telles Correia D. Hemolytic anemia potentially associated with aripiprazole. Psychiatry Clin Neurosci. 2018;72(12):876.
9. Yulianty MD, Cahaya N, Srikartika VM. Studi Penggunaan Antipsikotik dan Efek Samping pada Pasien Skizofrenia di Rumah Sakit Jiwa Sambang Lihum Kalimantan Selatan [Study of Antipsychotic Use and Side Effects in Schizophrenia Patients at Sambang Lihum Mental Hospital, South Kalimantan]. Jurnal Sains Farmasi & Klinis. 2017;3(2):153.
10. Lim JU, Lee JH, Kim JS, et al. Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patients. International Journal of COPD. 2017;12:2465-2475.
11. Jombo H, Ekwere T. A Cross-Sectional Study of the Impact of Antipsychotic Medications on the Hematological Profile of Patients with Schizophrenia in a Tertiary Health Facility in Uyo, South-South, Nigeria. Int Neuropsychiatr Dis J. 2018;11(2):1-9.
12. Saraswati I, Diniarti S. Prevalensi Obesitas Pada Penderita Skizofrenia yang Mendapatkan Terapi Antipsikotik Atipikal di Rumah Sakit Jiwa Provinsi Bali [Prevalence of Obesity in Schizophrenia Patients Receiving Atypical Antipsychotic Therapy at Bali Provincial Mental Hospital]. E-Jurnal Medika. 2019;8(5):84-93.
13. Aryani F, Sari O. Gambaran Pola Penggunaan Antipsikotik pada Pasien Skizofrenia di Ruang Rawat Inap Rumah Sakit Jiwa [Description of Antipsychotic Use Patterns in Schizophrenia Patients in Mental Hospital Inpatient Rooms]. Jurnal Manajemen dan Pelayanan Farmasi. 2016;6(1):35-40.
14. Smith S. Gender differences in antipsychotic prescribing. International Review of Psychiatry. 2010;22(5):472-484.
15. Seeman M v. Men and women respond differently to antipsychotic drugs. Neuropharmacology. 2020;163(April).
16. Marazziti D, Baroni S, Picchetti M, et al. Pharmacokinetics and pharmacodinamics of psychotropic drugs: Effect of sex. CNS Spectr. 2013;18(3):118-127.
17. Stępnicki P, Kondej M, Kaczor AA. Current concepts and treatments of schizophrenia. Molecules. 2018;23(8):1-16.
18. Akanni OE, Eegunranti A, Bamisaye O. Effects of Antipsychotic Chemotherapy on Haematological Parameters of Psychotic Patients in Lautech Teaching Hospital , Osogbo , Nigeria Effects of Antipsychotic Chemotherapy on Haematological Parameters of Psychotic Patients in Lautech Teaching Hospital. 2011;2(3):104-107.
19. Grover S, Shouan A, Chakrabarti S, Avasthi A. Haematological side effects associated with clozapine: A retrospective study from India. Asian J Psychiatr. 2020;48(10).
20. Lee, Jimmy MBBS Mm, Bies RP, Bhaloo ABms, Powell VBs, Remington GMP. Clozapine and Anemia : A 2-Year Follow-Up Study. J Clin Psychiatry. 2015;76(12):1642-1647.
21. Korkmaz S, Yıldız S, Korucu T, et al. Frequency of anemia in chronic psychiatry patients. Neuropsychiatr Dis Treat. 2015;11:2737-2741.
Additional Files
Published
How to Cite
Issue
Section
Citation Check
License
Copyright (c) 2024 Jessica Anggun Cristine Siregar, Innawati Jusup, Santoso Jaeri, Natalia Dewi Wardani (Author)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyrights Notice
Copyrights:
Researchers publishing manuscrips at Medica Hospitalis: Journal of Clinical Medicine agree with regulations as follow:
Copyrights of each article belong to researchers, and it is likewise the patent rights
Researchers admit that Medica Hospitalia: Journal of Clinical Medicine has the right of first publication
Researchers may submit manuscripts separately, manage non exclusive distribution of published manuscripts into other versions (such as: being sent to researchers’ institutional repository, publication in the books, etc), admitting that manuscripts have been firstly published at Medica Hospitalia: Journal of Clinical Medicine
License:
Medica Hospitalia: Journal of Clinical Medicine is disseminated based on provisions of Creative Common Attribution-Share Alike 4.0 Internasional It allows individuals to duplicate and disseminate manuscripts in any formats, to alter, compose and make derivatives of manuscripts for any purpose. You are not allowed to use manuscripts for commercial purposes. You should properly acknowledge, reference links, and state that alterations have been made. You can do so in proper ways, but it does not hint that the licensors support you or your usage.
